SCHEMBL32676017

SCHEMBL32676017

Cc1noc(-c2ccccc2)c1COc1cccc(C(=O)NNC(=O)c2ccc3ccccc3n2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.50
ALDH1A1 P00352 4/20 0.50
HPGD P15428 4/20 0.50
MAPT P10636 3/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
TSHR P16473 3/20 0.47
ATM Q13315 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
CYSLTR1 Q9Y271 2/20 0.47
GPBAR1 Q8TDU6 1/20 0.47
ALOX15 P16050 3/20 0.47
HSD17B10 Q99714 2/20 0.46
KDM4E B2RXH2 1/20 0.45
MEN1 O00255 1/20 0.45
TP53 P04637 1/20 0.45
ALOX12 P18054 1/20 0.45
KMT2A Q03164 1/20 0.45
SENP7 Q9BQF6 1/20 0.45
SENP6 Q9GZR1 1/20 0.45
RAC1 P63000 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32676006 0.89 ALDH1A1 (0.63) LMNAALDH1A1HPGDMAPTSMN1; SMN2
SCHEMBL32676007 0.87 ALDH1A1 (0.51) LMNAALDH1A1HPGDMAPTSMN1; SMN2
SCHEMBL30835899 0.85 CYSLTR1 (0.45) LMNAALDH1A1HPGDMAPTSMN1; SMN2
SCHEMBL32676014 0.85 ALDH1A1 (0.49) LMNAALDH1A1HPGDMAPTSMN1; SMN2
SCHEMBL30835869 0.83 ALDH1A1 (0.62) LMNAALDH1A1HPGDMAPTSMN1; SMN2
SCHEMBL32676012 0.81 ALDH1A1 (0.51) LMNAALDH1A1HPGDMAPTSMN1; SMN2
SCHEMBL4639160 0.79 ALDH1A1 (0.53) LMNAALDH1A1HPGDMAPTSMN1; SMN2
SCHEMBL32676009 0.77 ALDH1A1 (0.70) LMNAALDH1A1HPGDMAPTSMN1; SMN2
SCHEMBL32676015 0.75 HPGD (0.62) LMNAALDH1A1HPGDMAPTSMN1; SMN2
SCHEMBL32676013 0.74 AKR1C3 (0.56) LMNAALDH1A1HPGDMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260049064-A1 PROTEIN:PROTEIN INTERACTION INHIBITORS PURDUE RESEARCH FOUNDATION (US) 2026-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260049064-A1 PROTEIN:PROTEIN INTERACTION INHIBITORS PRMT6, PRMT5, PRMT1 LMNA 1656/4885ALDH1A1 4797/4885HPGD 4323/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.